Take Hope Further
For patients with HR+, HER2- early breast cancer at high risk of recurrence, she has all the hope in the world. She needs more than hope. Verzenio is the first and only CDK4 & 6 inhibitor approved in HR+, HER2-, EBC at high risk of recurrence, in addition to its original MBC indication.
Assisted art direction and design for Verzenio launch. In collaboration with CGI artists, created a pink world of hope representing the unmet need of women with high risk cancer.
The campaign Take Hope Further won gold for Global Campaign 2022 at the MM+M AWARDS.
The monarche butterfly, signifying Verzenio’s breakthrough trial, guides attendees at ASCO through the unmet need in early breast cancer and Verzenio’s efficacy.
Designed graphics and layout for Verzeniohcp.com. Worked with development and UX team.
